Acute myeloid leukemia cells harboring MLL fusion genes or with the acute promyelocytic leukemia phenotype are sensitive to the Bcl-2-selective inhibitor ABT-199.

ABSTRACT:

SUBMITTER: Niu X 

PROVIDER: S-EPMC4090260 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature